Diabetes mellitus type 2 (DMT2) is one of the modern societies’ highest public health threats. For a while, it was believed that DM had no impact on male reproductive function; however, new research has cast doubt on that assumption. To find out whether repaglinide and metformin may improve sperm motility and testosterone levels in diabetic and non-diabetic albino rats, researchers in this study used these two drugs to treat diabetes. Methods: Alloxan injections at three dosages of 120 mg/kg intraperitoneal produced type 2 diabetes in male rats. Experimental rats were classified into two main groups. The first group included four subgroups of male rats treated with alloxan (DM inducer). Each subgroup contained seven rats “1. Control without any treatment (positive control), 2. treated by 500 mg/kg metformin, 3. treated by 4 mg/kg repaglinide, and 4. treated by 500 mg/kg metformin and 4 mg/kg repaglinide”. The second group also includes four subgroups but without alloxan treated. Each subgroup has seven rats; all are categorized in the same initial group and receive identical treatment dosages.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.